Autoimmune neurological syndromes (AINS) with antibodies targeting glutamic acid decarboxylase 65 (anti-GAD65 AINS) show limited response to currently available immunotherapies and are associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results